D.A. Davidson & Co. Steris PLC Transaction History

D.A. Davidson & Co.

$12.1 Billion
Q4 2024

A detailed history of D.A. Davidson & Co. transactions in Steris PLC stock. As of the latest transaction made, D.A. Davidson & Co. holds 1,752 shares of STE stock, worth $384,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,752

Previous 1,839 4.73%

Holding current value

$384,090

Previous $446,000 19.28%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$204.34 - $235.7 $17,777 - $20,505	-87 Reduced 4.73%	1,752 $360,000
Q3 2024 Nov 13, 2024	SELL	$213.51 - $247.14 $4,270 - $4,942	-20 Reduced 1.08%	1,839 $446,000
Q2 2024 Jul 31, 2024	BUY	$199.01 - $236.0 $99,505 - $118,000	500 Added 36.79%	1,859 $408,000
Q1 2024 May 13, 2024	BUY	$213.53 - $236.03 $25,837 - $28,559	121 Added 9.77%	1,359 $305,000
Q4 2023 Feb 09, 2024	BUY	$197.44 - $227.52 $22,113 - $25,482	112 Added 9.95%	1,238 $272,000
Q3 2023 Nov 08, 2023	SELL	$217.85 - $233.02 $19,388 - $20,738	-89 Reduced 7.33%	1,126 $247,000
Q1 2023 Apr 25, 2023	SELL	$176.39 - $220.86 $2,645 - $3,312	-15 Reduced 1.22%	1,215 $232,000
Q4 2022 Feb 03, 2023	SELL	$160.98 - $199.08 $98,197 - $121,438	-610 Reduced 33.15%	1,230 $227,000
Q2 2022 Jul 28, 2022	BUY	$192.78 - $252.92 $8,675 - $11,381	45 Added 2.51%	1,840 $379,000
Q1 2022 May 12, 2022	SELL	$215.16 - $247.18 $215 - $247	-1 Reduced 0.06%	1,795 $434,000
Q4 2021 Jan 31, 2022	SELL	$206.02 - $245.17 $9,270 - $11,032	-45 Reduced 2.44%	1,796 $439,000
Q3 2021 Nov 15, 2021	SELL	$204.28 - $225.82 $7,149 - $7,903	-35 Reduced 1.87%	1,841 $376,000
Q2 2021 Aug 10, 2021	BUY	$188.43 - $216.47 $353,494 - $406,097	1,876 New	1,876 $387,000

Others Institutions Holding STE

# of Institutions

817

Shares Held

91.7M

Call Options Held

72.6K

Put Options Held

12K

View Full List

About STERIS plc

Ticker STE
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 100,015,000
Market Cap $21.9B
Description
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking prod...

More about STE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account